Article

Loss of Ena/VASP interferes with lamellipodium architecture, motility and…

medRxiv · 2020 · Damiano-Guercio, J.; Kurzawa, L.; Mueller, J.; Nemethova, M.; Dimchev, G.; Pokrant, T.; Bruehmann, S.; Linkner, J.; Blanchoin, L.; Sixt, M.; Rottner, K.; Faix, J.

Key facts

Title Loss of Ena/VASP interferes with lamellipodium architecture, motility and integrin-dependent adhesion
First author Damiano-Guercio, J.; Kurzawa, L.; Mueller, J.; Nemethova, M.; Dimchev, G.; Pokrant, T.; Bruehmann, S.; Linkner, J.; Blanchoin, L.; Sixt, M.; Rottner, K.; Faix, J.
Journal medRxiv
Published Jan 29, 2020
DOI 10.1101/2020.01.27.922450
Devices mentioned BK110039, K071580, K103302, K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840 and 13 more
Product codes mentioned CIT, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, NDS and 4 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature